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Brucellosis, a primary disease of domestic animals, is
caused by small, fastidious Gram-negative coccobacilli of
the genus Brucella.1 The incidence of brucellosis has shown
a mild decrease in Turkey according to data from the Min-
istry of Health; 7703 cases were reported in 2010.2 Humans
are commonly infected through ingestion of raw milk,
cheese, or meat, or through direct contact with infected
animals, and through inhalation of infectious aerosols.3Hematology and Oncology
ous Diseases Unit, Dıskapı,
m (A. Ozkaya-Parlakay).
.04.016
Society of Microbiology. PublisheClinical symptoms may vary, and include undulant fever,
abortion, orchitis, spondylitis, arthritis, endocarditis, en-
cephalitis, and asthenia.4 The aim of this study was to
evaluate the prevalence of acute, subacute, and chronic
brucellosis, and also to emphasize clinical and laboratory
findings of pediatric patients with brucellosis by comparing
with patients reported in the literature.Methods
In this study, 97 patients diagnosed with brucellosis at
Ankara Hematology Oncology Research Hospital between
January 2000 and December 2010 were evaluated retro-
spectively. Data analysis included demographic data, signs
and symptoms, physical findings, laboratory findings,d by Elsevier Taiwan LLC. All rights reserved.
Pediatric Brucellosis in Central Turkey 447treatment regimens, and outcome. Patients were classified
as having acute brucellosis (<3 months), subacute brucel-
losis (3e12 months), or chronic brucellosis (>12 months).
The study was approved by a local ethical committee.
The blood culture samples were studied with BacTAlert
systems (Organon Technica, Durham, NC, USA) for 21 days.
The diagnosis of brucellosis was made based on positive
Brucella STA test results (titer > 160) in the presence of
clinical signs and symptoms suggestive of brucellosis or a 4-
fold increase in the serum antibody concentration in a
serum sample obtained at 2e3 week intervals and/or
isolation of Brucella spp. from the blood, bone marrow, or
any body fluid or tissue culture. For data analysis, SPSS
version 15.0 (SPSS Inc., Chicago, IL, USA) was used. A p
value of 0.05 was considered statistically significant.Results
The characteristics and clinical findings of the 97 patients
are reviewed in Table 1.
Consumption of unpasteurized milk or dairy products
was significantly more common in patients with a family
history of brucellosis (96.9%, whereas patients with no
family history of brucellosis had consumption of raw milk in
72.3%, p Z 0.004). Initiation of symptoms was most com-
mon in spring and summer (65%).
By means of clinical findings, serum agglutination titers
(SAT) > 1/800 did not affect the presence of fever, weak-
ness, and arthralgia all together. Of patients with SAT < 1/Table 1 The characteristics and clinical findings of the
patients
Characteristics Mean
Mean age (y) 10  3.8
Mean duration of symptoms
before admission (d)
31.85  44.3
n (%)
Female 44.3
Living in a rural area 35.1
Consumption of unpasteurized
milk or dairy products
80.4
Family history of brucellosis 33
Symptoms
Fever 78.4
Arthralgia 76.3
Weakness 68
Clinical findings
Hepatomegaly 30.9
Splenomegaly 20.6
Hepatosplenomegaly 14.4
Arthritis 23.7
Monoarticular 19.6
Oligoarticular 4.1
Clinical diagnosis
Acute 75.3
Subacute 23.7
Chronic 1
Hospitalization 92.8800 43.9% had these three clinical findings, whereas 48.4%
of patients with SAT >1/800 had fever, weakness, and
arthralgia. The presence of arthralgia was not significantly
different in acute and subacute brucellosis cases (72.6% and
87.5%, respectively). Arthralgia was most common in the
knee joint (63.9%); arthralgia in the hip was present in
27.8% of our patients and in the sacroiliac joint was
encountered in 13.4% of patients, whereas sacroiliitis was
present only in one patient. The presence of fever, hepa-
tomegaly, splenomegaly, or arthritis was not significantly
different between patients with acute and subacute
brucellosis.
Laboratory studies of the patients are summarized in
Table 2. Laboratory evaluation, which included the pres-
ence of anemia, elevated C-reactive protein (CRP), and
sedimentation rates, did not significantly differ between
acute and subacute brucellosis patients.
The Rose Bengal test was positive in 67/70 patients
(95.7%), SAT was positive in 17/21 patients (80.9%), the
agglutination test with 2-mercaptoethanol was positive in
23/27 patients (85.1%), and blood culture was positive in
29/81 patients (35.8%). In patients with SAT > 1/800, 48.4%
had blood culture positivity, whereas in patients with
SAT < 1/800, 48.3% of them had blood culture positivity.
SAT titer did not affect blood culture positivity.
Neurobrucellosis was present in three patients, but ce-
rebrospinal fluid cultures were negative in all. They were
diagnosed with agglutination titer positivity in CSF.
When complications of brucellosis were evaluated,
23.7% had arthritis (19.6% monoarticular, 4.1% oli-
goarticular), 6.2% had pancytopenia, 3% had neuro-
brucellosis, 2.1% had hepatitis, 1% had osteomyelitis, 1%
had pneumonia, and 1% had sacroiliitis.
Treatment regimens were composed of doxycycline and
streptomycin in 29.9% of patients, doxycycline and rifampin
in 24.7% of cases, and cotrimoxazole and rifampin in 27.8%
of patients. The duration of therapy was 6 weeks in 94.9% of
patients, 12 weeks in 3.1% of patients, and 24 weeks in 3.1%
of patients. Relapse was observed in two patients who were
treated with doxycycline and rifampin. No relapse was
observed in these patients after 6 weeks of cotrimoxazole
and rifampin.Discussion
Brucellosis is one of the most common zoonoses worldwide
and remains endemic in the Mediterranean region, the
Middle East, West Asian countries, and also in Turkey.5,6
Studies from Turkey previously showed that a history of
consumption of unpasteurized dairy products was present
in 62.4e94.6% of patients with brucellosis.6e13 Similar to
the literature, consumption of unpasteurized dairy prod-
ucts was present in 80.4% of our patients. These results
suggest that necessary precautions should still be taken to
prevent consumption of such products. In pediatric
brucellosis cases, family history has been reported between
15.6% and 47%.14,15 In accordance with the literature, this
rate was 33% in our study. So screening of family members
when a patient with brucellosis is diagnosed is very
important. In accordance with literature, our cases had
Table 2 Laboratory studies of the cases
Laboratory findings n %
Anemia (<12 g/dL) 51 52.6
Leukopenia (<3.5  103/mL) 9 9.3
Thrombocytopenia (<150  103/mL) 14 14.4
Pancytopenia (Hgb < 12 g/dL, WBC
< 3.5  103/mL, plt < 150  103/mL)
6 6.2
Leukocytosis (>10.5  103/mL) 17 17.5
Thrombocytosis (>450  103/mL) 10 10.3
Elevated ESR (mm/h) 71 73.2
<20 26 26.8
20e50 52 53.8
>50e100 16 16.3
>100 3 3.1
Elevated CRP (mg/dL) 44 45.4
<1 53 54.6
1e10 41 42.2
>10e50 3 3.1
Elevated AST (IU/L) 40 41.3
<40 57 58.7
40e200 39 40.3
>200 1 1
Elevated ALT (IU/L) 35 35.6
<40 62 64.4
40e200 34 34.6
>200 1 1
Elevated AST-ALT(IU/L) 28 28.9
ALT Z alanine aminotransferase; AST Z aspartate amino-
transferase; CRP Z C-reactive protein; ESR Z erythrocyte
sedimentation rate; Hgb Z hemoglobin; WBC Z white blood
cell.
448 T. Yoldas et al.perennial accumulation in spring and summer due to raw
milk and dairy product consumption.13,16
In adult patients with brucellosis, the acute form is re-
ported to be observed in 25e77% of cases, the subacute
form in 12.5e59% of cases, and the chronic form in 5e27.5%
of cases.17 In a study, the acute form was diagnosed in
61.6% of the pediatric patients, the subacute form in 21.6%,
and the chronic form in 13.6% of the pediatric cases.13 In
our study, the acute form was present in 75.3% patients,
whereas the subacute form was in 23.7%, and the chronic
form was present in 1% of patients. This might be due to
earlier admission in children.
The most common clinical findings were reported as
fever and joint complaints, with prevalence of 41e85%
and 73e91%, respectively.16e22 Fever was present in 78.4%
and arthralgia in 76.3% of our patients. In addition,
arthritis was present in 23.7% of our patients (19.6%
monoarticular, 4.1% oligoarticular). In adult patients with
brucellosis, musculoskeletal involvement was the leading
complication, spondylodiscitis was reported in the old age
group, whereas sacroiliitis was reported in the young age
group.6 From the previous reports of 50 children who
presented with arthritis, 36 (72%) had monoarthritis; knee
(24 patients) and hip (23 cases) were the most commonly
involved joints,16 similar to our patients. In our patients,
sacroiliitis was present only in one patient, highlightingthat brucellosis has different outcomes according to the
age group.
Laboratory study is usually not helpful in differential
diagnosis of pediatric brucellosis; leukocyte count, CRP,
and erythrocyte sedimentation rate (ESR) are normal or
mildly elevated in most cases.18,22 Similarly, in our study
ESR was >55 mm/hour in 19.4% of cases and CRP was
negative in 54.6% of cases.
Diffuse hepatic involvement is usually reported during
the course of brucellosis. Involvement of the liver varies; a
slight increase in transaminase levels, mild hep-
atosplenomegaly, chronic suppurative disease, and more
rarely, acute hepatitis could be encountered.23 Elevated
transaminases were reported in 18e66% of pediatric
cases.8,24e26 In our study, aspartate aminotransferase (AST)
elevation was present in 41.3%, and alanine aminotrans-
ferase (ALT) elevation in 35.6% of our cases. In 28.9% of the
patients both ALT and AST were elevated. These rates of
elevated transaminases were similar to reported cases in
the literature.
Hematological studies during the active course of
brucellosis showed that leukopenia occurred in 33% of
patients, anemia in 44%, thrombocytopenia in 5%, and
pancytopenia in 14%.27,28 Furthermore, pancytopenia was
detected in 10% of children suffering brucellosis.29 The
frequency of pancytopenia with brucellosis varies from 3%
to 21% in the previous studies, being relatively higher in
adults than children.30,31 The possible mechanisms sug-
gested for pancytopenia include autoimmune process,
hypersplenism, granuloma formation in the bone marrow,
phagocytosis of formed elements by reticuloendothelial
cells, or bone marrow depression due to the associated
septicemia. In our study, anemia was present in 52.6%,
thrombocytopenia in 14.4%, leukopenia in 9.3%, leuko-
cytosis in 11.3%, and thrombocytosis in 6.2% of the
patients.
Neurobrucellosis is a rare complication of brucellosis
that could be diagnosed with the clinical picture of men-
ingitis and meningoencephalitis in most cases.22 Its preva-
lence has been reported to range between 1.7% and
17.8%17,32e36 in various studies. The mortality due to neu-
robrucellosis ranges between 0% and 5.5%, depending on
the use of appropriate antibiotics.37 There was no mortality
due to neurobrucellosis in our patients.
Depending on the type of antibiotic and duration of
treatment, the relapse rate in pediatric brucellosis cases
was reported between 0% and 85%.17,26,28,37 In our study,
only two patients who were treated with doxycycline and
streptomycin (3 weeks; 2.1%) had relapse of the disease.
The relapse rates of our patients were near to the lower
limits compared to studies in the literature. As most of our
patients received therapy for 6 weeks (94.9%), a lower
relapse rate might be possibly related with longer duration
of therapy compared to patients receiving 3 weeks of
therapy.
In conclusion, as brucellosis is still endemic in Turkey,
strict control of veterinary studies and precautions to pre-
vent consumption of raw milk products is mandatory. In
patients admitted with fever, arthralgia, fatigue, and
sweating, brucellosis should be kept in mind. In addition,
family of patients with brucellosis must be screened.
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